封面
市場調查報告書
商品編碼
2143397

環狀RNA合成市場:依產品類型、應用、最終用戶、國家及地區分類-全球產業分析、市場規模、市場佔有率及2026年至2033年預測

CircRNA Synthesis Market, By Product Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

出版日期: | 出版商: AnalystView Market Insights | 英文 305 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年 CircRNA 合成市值將達到 2.107 億美元,並預計從 2026 年到 2033 年將以 16.2% 的複合年成長率成長。

環狀RNA(circRNA)的合成涉及設計、體外轉錄、環化、純化和品管等多個步驟,最終產生共用閉合的RNA,用於研發和治療開發。與傳統的線性RNA生產不同,此流程需要精確控制環化效率,並去除未環化的RNA、雙鏈RNA、切割產物和其他免疫抗原性雜質。因此,該市場不僅包括用於支持蛋白質表現、藥物發現、疫苗、基因治療和生物標記研究的合成設備和試劑,還包括專業的契約製造服務。 2025年發表在《先進科學》(Advanced Science)雜誌上的一項研究表明,結合酶和纖維素的整合純化策略可以將circRNA的產量提高10倍以上,同時降低免疫活化。這項發現促使採購重點從單純的RNA生成轉向可重複的環化、純度、分析檢驗和可擴展的工作流程。

環狀RNA合成市場-市場動態

對高純度和更具可擴展性的循環化工作流程的需求

生產製造的主要挑戰在於如何將環狀RNA(circRNA)從實驗室實驗階段轉化為可用於高要求轉化研究的材料。製程控制是關鍵的差異化因素,因為傳統的連接和核酶方法在序列、長度、純化和產品特異性方面有其限制。 2025年發表在《自然通訊》(Nature Communications)上的一項研究表明,化學環化對長度為35至4000個核苷酸的RNA均有效,環化效率高達60%,這展現了合成研究更廣泛的設計可能性。同時,研究人員仍在優先考慮無痕設計和更有效的雜質去除。最終目標並非僅僅是提高circRNA的產量。供應商現在必須提供可控的環化、靈活的定序、純化和表徵,並將其整合到統一的生產流程中。製程控制必須貫穿整個製程。供應商必須繼續將製程控制作為核心優先事項。

環狀RNA合成市場—市場細分分析:

全球 circRNA 合成市場按產品類型、應用、最終用戶和地區進行細分。

按產品類型進行細分,可以揭示每個實驗室如何平衡內部流程控制與技術專長。當機構需要轉錄、純化、層析法和分析工作流程時,儀器的選擇至關重要。試劑和試劑盒無需建造整個平台即可提供酵素、轉錄組分、連接系統和純化試劑。服務佔據著獨特的地位,將定序、環化、純化和品管外包給專業機構。例如,金斯瑞提供三種客製化方法,包括無痕PIE和無痕T4連接,涵蓋編碼和非編碼領域的應用。商業性差異源自於工作流程的所有權歸屬。先進的研究團隊可以建立流程,而藥物開發公司則越來越傾向於整合生產和表徵。

從應用角度來看,環狀RNA(circRNA)的需求隨著其從生物學領域轉向治療開發領域的轉變而顯著變化。在藥物發現領域,circRNA被用於研究蛋白質表現、RNA功能、標靶生物學以及可能的作用機制。這就產生了對序列設計和快速修飾的需求。同時,在治療開發領域,純度、可重複性、體內轉化性能、免疫抗原性以及與藥物遞送系統的兼容性至關重要,因為生產細節會影響後續結果。 ClinicalTrials.gov網站列出了一項使用環狀RNA衍生腫瘤抗原疫苗的I/II期臨床試驗,該試驗涉及60名患者,計劃於2025年12月啟動。這項進展對治療開發領域的生產提出了新的要求。 circRNA供應商需要將合成品質與特定應用的生物學檢驗結合,而不是將RNA生產視為一個獨立的實驗過程。

環狀RNA合成市場—區域洞察

亞太地區正在建構一個強大的環狀RNA轉化生態系統,學術研究、生物技術進步和法律規範在中國得到整合。 2025年1月,上海賽科生物醫藥宣布其環狀RNA療法HM2002獲得中國國家藥品監督管理局(NMPA)的臨床實驗試驗申請(IND)批准。該公司稱這是中國首個獲得此項批准的環狀RNA療法。這一里程碑事件的影響遠不止於HM2002療法本身。它預示著對生產製造、嚴格的雜質控制、詳細的分析表徵以及可擴展的環化技術的需求日益成長。中國將繼續推動合成研究,包括2025年「無痕環化」和「自剪接系統」的研究。該地區不僅是環狀RNA研究的受益者,更透過轉化應用和創新積極塑造這項技術。研發與科學的協同作用使亞太地區成為該領域的重要驅動力。

北美地區 circRNA 的發展深受 RNA 技術供應商、藥物研發公司和美國監管流程之間互動的影響。 2025 年 5 月 30 日,CircCode 公司宣布其產品 HM2002 已獲得美國食品藥物管理局 (FDA) 的臨床試驗申請 (IND) 批准,用於治療心臟病,從而將該療法的監管路徑擴展到中國以外的地區。另據 FDA 孤兒藥認定資料庫顯示,一種表達肝細胞生長因子的環狀 RNA 療法於 2025 年 10 月 23 日獲得孤兒藥認定,用於治療閉塞性血栓性脈管炎。這些監管方面的進展凸顯了以治療級品質合成 circRNA 並進行嚴格文件記錄的必要性。關鍵領域包括身份檢驗、純度評估、穩定生產和嚴格的生產控制。北美在 circRNA 的發展中發揮核心作用,從實驗室規模的實驗到成熟的治療項目,都離不開北美的支持。市場正朝著規範的生產標準和嚴格的分析方法轉變,這意味著 circRNA 的發展正從研究級向可用於臨床開發的階段邁進。

目錄

第1章 環狀RNA合成市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 環狀RNA合成的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章:環狀RNA合成產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章:環狀RNA合成市場:地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 環狀RNA合成市場概況

  • 2025年環狀RNA合成市佔分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 環狀RNA合成市場:依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析:按產品類型
    • 裝置
    • 試劑和試劑盒
    • 服務

第8章 環狀RNA合成市場:依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析:按應用領域
    • 藥物發現
    • 藥物研發
    • 其他

第9章:環狀RNA合成市場:依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析:按最終用戶分類
    • 學術研究機構
    • 製藥和生物技術公司
    • 其他

第10章:環狀RNA合成市場:依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商:北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商:歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商:亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商:拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商:中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章:主要供應商分析:環狀RNA合成產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • GenScript
    • LGC Biosearch Technologies
    • Creative Biogene
    • SBS Genetech
    • Applied Biological Materials Inc.
    • Amerigo Scientific
    • BOC Sciences
    • GeneCopoeia, Inc.
    • Guangzhou Geneseed Biotech. Co., Ltd.
    • Creative Biolabs
    • Thermo Fisher Scientific
    • Azenta/GENEWIZ
    • VectorBuilder
    • Twist Bioscience
    • TriLink BioTechnologies
    • Others

第12章:AnalystView 的全景視圖

簡介目錄
Product Code: ANV7557

CircRNA Synthesis Market size was valued at US$ 210.7 Million in 2025, expanding at a CAGR of 16.2% from 2026 to 2033.

CircRNA synthesis encompasses the design, in vitro transcription, circularization, purification, and quality control processes that contribute to the production of covalently closed RNA for research and therapeutic development. Unlike traditional linear RNA production, the workflow must control both the efficiency of circularization and the removal of uncircularized RNA, double-stranded RNA, truncated products, and other immunogenic impurities. Hence, the market also comprises synthesis instruments and reagents along with specialized custom production services to support protein expression, drug discovery, vaccines, gene therapy, and biomarker research. An integrated enzymatic and cellulose-based purification strategy has been demonstrated in a 2025 Advanced Science study to increase the yield of CircRNA manufacturing by more than 10-fold, as well as to reduce immune activation. This evidence shifts buying priorities to reproducible circularization, purity, analytical validation, and scalable workflows rather than just RNA generation.

CircRNA Synthesis Market- Market Dynamics

Demand for Higher Purity and More Scalable Circularization Workflows

The main manufacturing challenge is moving CircRNA from laboratory experiments to material that can be used in demanding translational studies. Traditional ligation and ribozyme methods can create limits on sequence, length, purification, and by-products, so process control becomes a differentiator. A 2025 Nature Communications study showed that chemical circularization works for RNA lengths from 35 to 4,000 nucleotides and that circularization efficiency can reach up to 60 percent, showing that synthesis research is expanding the design space. Meanwhile, researchers continue to stress scar-free designs and better impurity removal. The final requirement is not more CircRNA output; suppliers must now offer controllable circularization, flexible sequences, purification, and characterization as a single integrated production workflow. Process control must be maintained throughout. Suppliers must keep process control as a core focus.

CircRNA Synthesis Market- Segmentation Analysis:

The Global CircRNA Synthesis Market is segmented on the basis of Product Type, Application, End User, and Region.

By product type, product type segmentation shows how laboratories balance internal process control with technical expertise. Instruments matter when organizations need transcription, purification, chromatography, and analytical workflows. Reagents and kits provide access to enzymes, transcription components, ligation systems, and purification chemistry without building a whole platform. Services occupy a unique position because they transfer sequence design, circularization, purification, and quality control to specialist providers. GenScript, for example, offers three custom methods-PIE with a scarless PIE and scarless T4-ligation-covering both coding and non-coding uses. The commercial difference comes from who owns the workflow: advanced research groups can build processes while therapeutic developers increasingly prefer integrated production and characterization.

By application, application needs shift significantly when CircRNA moves from biology to therapeutic work. Drug discovery uses CircRNA to study protein expression, RNA function, target biology, and possible mechanisms. This creates a demand for sequence designs and rapid changes. Therapeutics development emphasizes purity, reproducibility, translation performance, immunogenicity, and delivery compatibility because manufacturing details can change downstream results. ClinicalTrials.gov listed a Phase I/II study using a circular RNA-derived tumor-antigen vaccine with 60 patients, with a planned start in December 2025. This move creates a manufacturing need in therapeutics development: CircRNA suppliers must link synthesis quality with application-specific biological checks instead of treating RNA production as a separate lab step.

CircRNA Synthesis Market- Geographical Insights

Asia Pacific has built a strong translational ecosystem around CircRNA, with China bringing together academic research, biotechnology advancement, and regulatory oversight. In January 2025, Shanghai CirCode Biomed announced that its HM2002 circular RNA therapeutic had received Investigational New Drug approval from China's NMPA. The company described this as the CircRNA therapeutic to receive such approval in China. The impact of this milestone goes beyond the HM2002 therapy itself. It signals a growing need for manufacturing, tight control over impurities, detailed analytical characterization, and scalable circularization techniques. China continues to advance synthesis research, including work in 2025 on scarless circularization and self-splicing systems. This region is not merely a consumer of CircRNA research; it is actively shaping the technology through both translational ambitions and innovation. The synergy between development and science makes Asia Pacific a key driver in the field.

North America's involvement in CircRNA is heavily influenced by the interplay among RNA technology providers, therapeutic developers, and U.S. regulatory processes. On May 30, 2025, CirCode announced that HM2002 had received FDA IND clearance for heart disease, expanding the therapy's regulatory journey beyond China. In another development, the FDA's orphan-designation database shows that a circular RNA therapy expressing hepatocyte growth factor was granted orphan designation on October 23, 2025, for thromboangiitis obliterans. These regulatory steps emphasize the need for quality therapeutic-grade synthesis and rigorous documentation. Key areas include identity verification, purity assessment, consistent production, and robust manufacturing controls. North America's role is central in moving CircRNA from lab-scale experiments to developed therapeutic programs. The market is shifting toward formalized production standards and analytical rigor, marking a transition from research-grade to development-ready CircRNA.

CircRNA Synthesis Market- Competitive Landscape:

Competition is now distinguished by the ability to manage the CircRNA workflow instead of just providing RNA reagents. GenScript combines custom synthesis with several circularization methods and purification, while GENEWIZ from Azenta pushes a unique group I-intron workflow for high-quality circular RNA production. Creative Biolabs also integrates sequence design, circularization, purification, and validation that focuses on CircRNA applications. Technology developers compete by enhancing cellular performance and improving therapeutic outcomes. Circio states that in its 2025 report, the new circVec 4.0 platform boosted protein output by 50 percent over the earlier circVec 3.2 version. What this means for competition is a move toward process power designed for specific uses and clear performance metrics rather than merely the ability to make CircRNA.

Recent Developments:

In March 2025, researchers created a multi-step purification process that used enzymes and cellulose-based methods to remove the main immunogenic CircRNA by-products. After refining the process, they observed more than a ten-fold improvement in CircRNA production yield.

In July 2025, scientists introduced a chemical circularization technique for RNA made through in vitro transcription. This method was designed to expand the types of structures that can be built using chemical synthesis. It successfully produced chem-CircRNAs ranging from 35 to 4,000 nucleotides in length, achieving circularization efficiency as high as 60 percent.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CIRCRNA SYNTHESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GenScript
  • LGC Biosearch Technologies
  • Creative Biogene
  • SBS Genetech
  • Applied Biological Materials Inc.
  • Amerigo Scientific
  • BOC Sciences
  • GeneCopoeia, Inc.
  • Guangzhou Geneseed Biotech. Co., Ltd.
  • Creative Biolabs
  • Thermo Fisher Scientific
  • Azenta / GENEWIZ
  • VectorBuilder
  • Twist Bioscience
  • TriLink BioTechnologies
  • Others

GLOBAL CIRCRNA SYNTHESIS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Instruments
  • Reagents & Kits
  • Services

GLOBAL CIRCRNA SYNTHESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Drug Discovery
  • Therapeutics Development
  • Others

GLOBAL CIRCRNA SYNTHESIS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

GLOBAL CIRCRNA SYNTHESIS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. CircRNA Synthesis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CircRNA Synthesis Market Snippet by Product Type
    • 2.1.2. CircRNA Synthesis Market Snippet by Application
    • 2.1.3. CircRNA Synthesis Market Snippet by End User
    • 2.1.4. CircRNA Synthesis Market Snippet by Country
    • 2.1.5. CircRNA Synthesis Market Snippet by Region
  • 2.2. Competitive Insights

3. CircRNA Synthesis Key Market Trends

  • 3.1. CircRNA Synthesis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CircRNA Synthesis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CircRNA Synthesis Market Opportunities
  • 3.4. CircRNA Synthesis Market Future Trends

4. CircRNA Synthesis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CircRNA Synthesis Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CircRNA Synthesis Market Landscape

  • 6.1. CircRNA Synthesis Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CircRNA Synthesis Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Instruments
    • 7.1.3. Reagents & Kits
    • 7.1.4. Services

8. CircRNA Synthesis Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Drug Discovery
    • 8.1.3. Therapeutics Development
    • 8.1.4. Others

9. CircRNA Synthesis Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Academic & Research Institutes
    • 9.1.3. Pharmaceutical & Biotechnology Companies
    • 9.1.4. Others

10. CircRNA Synthesis Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. CircRNA Synthesis Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. CircRNA Synthesis Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. CircRNA Synthesis Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. CircRNA Synthesis Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. CircRNA Synthesis Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- CircRNA Synthesis Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. GenScript
    • 11.2.2. LGC Biosearch Technologies
    • 11.2.3. Creative Biogene
    • 11.2.4. SBS Genetech
    • 11.2.5. Applied Biological Materials Inc.
    • 11.2.6. Amerigo Scientific
    • 11.2.7. BOC Sciences
    • 11.2.8. GeneCopoeia, Inc.
    • 11.2.9. Guangzhou Geneseed Biotech. Co., Ltd.
    • 11.2.10. Creative Biolabs
    • 11.2.11. Thermo Fisher Scientific
    • 11.2.12. Azenta / GENEWIZ
    • 11.2.13. VectorBuilder
    • 11.2.14. Twist Bioscience
    • 11.2.15. TriLink BioTechnologies
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us